PMID- 33746564
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240331
IS  - 1357-714X (Print)
IS  - 1369-1643 (Electronic)
IS  - 1357-714X (Linking)
VI  - 2021
DP  - 2021
TI  - Comparison of Publication Rates for Musculoskeletal Oncology Abstracts Presented 
      at National Meetings.
PG  - 8326318
LID - 10.1155/2021/8326318 [doi]
LID - 8326318
AB  - BACKGROUND: Scientific meetings provide a forum to disseminate new research and 
      advance patient care. The American Academy of Orthopaedic Surgeons (AAOS), 
      Connective Tissue Oncology Society (CTOS), and Musculoskeletal Tumor Society 
      (MSTS) annual meetings are examples of such gatherings in the field of 
      musculoskeletal oncology. After a review of select MSTS abstracts from 1991 to 
      1999 revealed a 41% publication rate in scientific journals, previous authors 
      cautioned meeting attendees that the majority of abstracts may not survive 
      rigorous peer review and may not be scientifically valid. Since two decades have 
      passed, this study reexamined publication rates and characteristics in a 
      contemporary and expanded cohort of oncology abstracts presented at the AAOS, 
      CTOS, and MSTS annual meetings. METHODS: 1408 podium and poster abstracts from 
      the AAOS (oncology-focused from 2013 to 2015), CTOS (2012 to 2014), and MSTS 
      (2012 to 2014) annual meetings were reviewed to allow for a four-year publication 
      window. Searches were performed with PubMed and Google Scholar databases to 
      identify full-text publications using abstract keywords. Characteristics of each 
      abstract and resulting publication were collected. Statistical analysis was 
      performed using the chi-square and Kruskal-Wallis tests for time-independent 
      comparisons, and the log-rank test after reverse Kaplan-Meier analysis for 
      time-dependent comparisons. RESULTS: Abstract publication rates overall were 
      higher for podium presentations (67%, 280 of 415) compared to poster 
      presentations (53%, 530 of 993; p < 0.001). When both abstract types were 
      combined, differences between meetings did not meet statistical significance 
      (AAOS: 65%, 106 of 162; CTOS: 57%, 521 of 909; MSTS: 54%, 183 of 337, p=0.06). 
      Abstracts from AAOS meetings were more often published prior to the first day of 
      the meeting (AAOS: 24%, 25 of 106; CTOS: 10%, 52 of 521; MSTS: 14%, 25 of 183; p 
      < 0.01). After excluding previously published abstracts, AAOS abstracts had the 
      shortest time to publication (median: 10.8 months, interquartile range (IQR): 4.4 
      to 18.8 months), compared to those from CTOS (16.0 months, 8.4 to 25.9 months, p 
      < 0.01) and MSTS (15 months, 7.9 to 25.0 months, p < 0.01) meetings. CTOS 
      abstracts were published in higher impact journals (median: 3.7, IQR: 2.9 to 
      5.9), compared to those from AAOS (2.9, 1.9 to 3.2, p < 0.01) and MSTS (3.1, 2.3 
      to 3.1, p < 0.01) meetings. Finally, 7.7% (62 of 810) of published abstracts were 
      presented at more than one meeting. CONCLUSIONS: Publication rates in this study 
      were higher than previous reports in musculoskeletal oncology and comparable or 
      better than recent reports for other orthopedic meetings. Comparisons across the 
      AAOS, CTOS, and MSTS annual meetings highlight notable differences but suggest 
      similarity overall in the quality of evidence presented with little overlap 
      between meetings. Taken together, this study points to progress in the review 
      processes used by the program committees, reaffirms the importance of critical 
      appraisal when considering abstract findings, and supports the continued 
      organization of multiple scientific meetings in musculoskeletal oncology.
CI  - Copyright (c) 2021 Christopher D. Collier et al.
FAU - Collier, Christopher D
AU  - Collier CD
AUID- ORCID: 0000-0003-2639-4290
AD  - Department of Orthopaedic Surgery, Indiana University School of Medicine, 1130 W 
      Michigan Street, Fesler Hall 115, Indianapolis, IN 46202, USA.
FAU - Quereshy, Humzah A
AU  - Quereshy HA
AD  - Department of Orthopaedics, University Hospitals Cleveland Medical Center, Case 
      Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA.
FAU - Getty, Patrick J
AU  - Getty PJ
AD  - Department of Orthopaedics, University Hospitals Cleveland Medical Center, Case 
      Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA.
LA  - eng
PT  - Journal Article
DEP - 20210305
PL  - Egypt
TA  - Sarcoma
JT  - Sarcoma
JID - 9709257
PMC - PMC7960053
COIS- The authors report no conflicts of interest related to this work.
EDAT- 2021/03/23 06:00
MHDA- 2021/03/23 06:01
PMCR- 2021/03/05
CRDT- 2021/03/22 08:05
PHST- 2020/07/09 00:00 [received]
PHST- 2021/01/10 00:00 [revised]
PHST- 2021/02/20 00:00 [accepted]
PHST- 2021/03/22 08:05 [entrez]
PHST- 2021/03/23 06:00 [pubmed]
PHST- 2021/03/23 06:01 [medline]
PHST- 2021/03/05 00:00 [pmc-release]
AID - 10.1155/2021/8326318 [doi]
PST - epublish
SO  - Sarcoma. 2021 Mar 5;2021:8326318. doi: 10.1155/2021/8326318. eCollection 2021.